Name:
Brevibacterium sanguinis Wauters et al. 2004
DSM No.:
15679 dsm-15679 dsm15679 dsm 15679 Brevibacterium sanguinis
Strain designation:
CF105
Other collection no.
or WDCM no.:
CCUG 47859
Isolated from:
human blood
Date of sampling:
before 16.06.2003
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- G. Wauters; CF105 <- G. Haase
Summary and
additional information:
<- G. Wauters; CF105 <- G. Haase. Human blood; Belgium. Taxonomy/description (9308). (Medium 693 or 92, 37°C)
Risk group:
2 (classification according to German
TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
